<iframe src="//www.googletagmanager.com/ns.html?id=GTM-MX3DVL" height="0" width="0" style="display:none;visibility:hidden"></iframe>Pestalozzi advised Akorn Inc. in its acquisition of Excelvision AG from Fareva SA (Luxembourg) | Pestalozzi Attorneys at Law

Pestalozzi advised Akorn Inc. in its acquisition of Excelvision AG from Fareva SA (Luxembourg)

12.2014

Akorn, Inc. (NADAQ: AKRX) is a niche pharmaceutical company that develops, manufactures and markets generic and branded prescription pharmaceuticals as well as animal and consumer health products. They specialize in difficult-to-manufacture sterile and non-sterile dosage forms including: ophthalmics, injectables, oral liquids, otics, topicals, inhalants, and nasal sprays. In 2014 Akorn was informed that Fareva intended to liquidate Excelvision, one of Akorn's contract manufacturer, for financial considerations. Since Excelvision was an important contract manufacturer and Akorn believed that it could more efficiently make use of Excelvision's production capacity, it decided to acquire the company.

To the top